Figure 4
Figure 4. The expanded Vδ2− γδ T cells in CMV-experienced donors are mainly TEMRA cells. Freshly collected blood from CMV− or CMV+ blood donors was stained for 6-color flow cytometric analysis with mAbs directed against CD3, γδ TCR, Vδ2 and activation markers or NKR. Raw data are presented in Figure S3. (A) Percentages of Vδ2+ or Vδ2− γδ T cells positive for CD27 and/or CD45RA in 9 CMV− () and 9 CMV+ donors (●). The short line represents the mean percentage for each cohort. (B) Mean (± SD) percentages of positive cells (for CD57, CD158a/h, b/j, i, e, CD94, NKG2A, NKG2C, or NKp80) or negative cells (for CD27) among Vδ2− γδ T cells from CMV− or CMV+ blood donors.

The expanded Vδ2 γδ T cells in CMV-experienced donors are mainly TEMRA cells. Freshly collected blood from CMV or CMV+ blood donors was stained for 6-color flow cytometric analysis with mAbs directed against CD3, γδ TCR, Vδ2 and activation markers or NKR. Raw data are presented in Figure S3. (A) Percentages of Vδ2+ or Vδ2 γδ T cells positive for CD27 and/or CD45RA in 9 CMV () and 9 CMV+ donors (●). The short line represents the mean percentage for each cohort. (B) Mean (± SD) percentages of positive cells (for CD57, CD158a/h, b/j, i, e, CD94, NKG2A, NKG2C, or NKp80) or negative cells (for CD27) among Vδ2 γδ T cells from CMV or CMV+ blood donors.

Close Modal

or Create an Account

Close Modal
Close Modal